Literature DB >> 20665416

[Parathyroid hormone injection to counteract delayed bone fractures].

C E Brunnemann1, E C Reisinger, D Ganzer, H C Schober.   

Abstract

CASE HISTORY AND CLINICAL
FINDINGS: Two women, aged 71 and 53 years with periprosthetic fractures of the left femur and an 18 year old man with a non-union of fracture of the left radius presented for assessment and treatment. INVESTIGATIONS: Serial radiographs showed that osteosynthesis and/or autogenous bone-grafting and multiple revisions had not resulted in healing of the fractures. TREATMENT AND CLINICAL COURSE: In all three patients parathyroid hormone (teriparatide), 20 to 60 microg, was injected subcutaneously once daily for 6 - 10 weeks. Subsequently a stable consolidation of the bone occurred in all of them.
CONCLUSION: Administration of parathyroid hormone can induce stable consolidation of the bone in non-unions and delayed healing of bone fractures. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Year:  2010        PMID: 20665416     DOI: 10.1055/s-0030-1262443

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Osseous Consolidation of an Aseptic Delayed Union of a Lower Leg Fracture after Parathyroid Hormone Therapy - A Case Report.

Authors:  Ilko Kastirr; Sebastian Radmer; Reimer Andresen; Hans-Christof Schober
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  An unexpected healing of an established non union of the radial neck through teriparatide: A case report and review of literature.

Authors:  Bhavuk Garg; Sahil Batra; Vivek Dixit
Journal:  J Clin Orthop Trauma       Date:  2017-10-27

Review 3.  Orthopaedic surgeons' strategies in pharmacological treatment of fragility fractures.

Authors:  Antonio Capone; Francesca Orgiano; Francesca Pianu; Marco Planta
Journal:  Clin Cases Miner Bone Metab       Date:  2014-05

4.  Teriparatide as a nonoperative treatment for tibial and femoral fracture nonunion: A case report.

Authors:  Li Xiaofeng; Xu Daxia; Chen Yunzhen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.